Fabtech Technologies Ltd Share Price – NSE /  BSE

Trading, Small Cap

The company stated that the closing year witnessed heightened global volatility, including disruptions in logistics, freight movements, and cost escalations across key inputs.

Despite these transient challenges in the final weeks of the year, the company has successfully navigated the environment with minimal impact on its overall performance, reflecting the strength and resilience of its execution model.

The company continued to expand its presence in high-growth segments, including entry into the animal health space.

Geographically, Fabtech strengthened its international footprint with vaccine and advanced pharmaceutical projects in Saudi Arabia and large-scale projects across Africa.

Looking ahead, the company remains optimistic about its growth trajectory, supported by a robust order book, expanding market presence, and continued focus on complex, value-accretive projects,? Fabtech Technologies said in a statement.

Fabtech Technologies is engaged in the business of providing turnkey projects solutions to pharmaceutical and allied industries by way of supplying pharmaceutical machineries/equipment, in house designing and engineering and undertaking other activities as required in various turnkey projects.

The company?s consolidated net profit declined 37.83% to Rs 3.32 crore despite of 23.03% increase in revenue from operations to Rs 76.18 crore in H1 FY26 over H1 FY25.

Fabtech Technologies has secured an export order valued at Rs 63.6 crore with a company in West Africa for supply, installation and commissioning of the infrastructure for oral solid dosage facility.

Powered by Capital Market - Live News

According to an exchange filing, the contract involves the supply, installation, and commissioning of infrastructure for an Oral Solid Dosage (OSD) facility.

The project is scheduled to be executed within 23?27 months from the date of receipt of the advance payment. The company stated that it received the order on 14 February 2026.

Fabtech Technologies Cleanrooms (FTCL) is an India-focused cleanroom infrastructure company, offering in-house manufactured modular partitions, HVAC, and MEP systems for pharma, biotech, semiconductor, and green energy sectors.

The company?s consolidated net profit declined 37.83% to Rs 3.32 crore despite of 23.03% increase in revenue from operations to Rs 76.18 crore in H1 FY26 over H1 FY25.

The counter shed 0.53% to Rs 160.55 on the BSE.

Powered by Capital Market - Live News

Net loss of Fabtech Technologies reported to Rs 5.68 crore in the quarter ended December 2025 as against net profit of Rs 20.46 crore during the previous quarter ended December 2024. Sales declined 39.84% to Rs 62.76 crore in the quarter ended December 2025 as against Rs 104.32 crore during the previous quarter ended December 2024.

Powered by Capital Market - Live News